What is the recommended dose and duration of Macrobid (nitrofurantoin) for treating uncomplicated urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid (Nitrofurantoin) Dosing for UTI

For uncomplicated urinary tract infections (UTIs), nitrofurantoin monohydrate/macrocrystals (Macrobid) should be dosed at 100 mg twice daily for 5 days. 1, 2

Standard Dosing Regimen

  • The Infectious Diseases Society of America (IDSA) and the European Society for Microbiology and Infectious Diseases recommend nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days as a first-line treatment for uncomplicated UTIs in women 3, 1
  • This 5-day regimen has been shown to achieve clinical cure rates of 88-93% and bacterial cure rates of 81-92% 1, 2
  • The European Association of Urology also endorses nitrofurantoin as a first-line agent for uncomplicated cystitis with the same dosing recommendation 1

Efficacy Data

  • A 5-day course of nitrofurantoin (100 mg twice daily) has demonstrated equivalent efficacy to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in clinical trials 3, 1
  • In comparative studies, nitrofurantoin shows clinical cure rates similar to ciprofloxacin and trimethoprim-sulfamethoxazole 1
  • Nitrofurantoin achieves early clinical cure rates of approximately 90% and bacterial cure rates of 92% 3

Important Considerations and Contraindications

  • Nitrofurantoin is contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased risk of toxicity 2
  • For patients with renal impairment, alternative agents such as trimethoprim-sulfamethoxazole or fosfomycin trometamol should be considered 2
  • Common side effects include nausea and headache, with adverse event rates ranging from 5.6-34% across studies 1

Special Populations

  • For male patients with uncomplicated UTIs, a longer duration of 7 days is often used, though evidence is more limited 4
  • For women with diabetes but without voiding abnormalities, treatment approach should be similar to women without diabetes 4

Alternative Formulations

  • While some countries use different formulations (macrocrystals 50-100 mg four times daily), the monohydrate/macrocrystals formulation at 100 mg twice daily is the standard in the US and most countries 1, 5

Duration Considerations

  • Although some UK guidelines suggest 3-day courses, most international guidelines recommend 5 days of therapy 6
  • The evidence more strongly supports the 5-day regimen, which balances efficacy with minimizing resistance development 3, 1, 2

Nitrofurantoin remains a valuable first-line agent for uncomplicated UTIs due to its continued effectiveness and low rates of resistance development compared to other antimicrobials 1, 4.

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.